中医药科技创新明确九大任务

2017-06-16 佚名 健康报

科技部、国家中医药管理局近日联合印发《“十三五”中医药科技创新专项规划》。《规划》提出,到2020年,建立更加协同、高效、开放的中医药科技创新体系,解决一批制约中医药发展的关键科学问题,突破一批制约中医药发展的关键核心技术,加速推进中医药现代化和国际化发展,构建更加符合中医药传承与创新特点的研究模式和技术体系,显着增强中医药科技创新能力。

科技部、国家中医药管理局近日联合印发《“十三五”中医药科技创新专项规划》。《规划》提出,到2020年,建立更加协同、高效、开放的中医药科技创新体系,解决一批制约中医药发展的关键科学问题,突破一批制约中医药发展的关键核心技术,加速推进中医药现代化和国际化发展,构建更加符合中医药传承与创新特点的研究模式和技术体系,显着增强中医药科技创新能力。

《规划》提出,构建中医传承平台,系统整理、挖掘和传承100位知名中医专家的学术经验;建设1500种中医药基本古籍文献数字与资源信息库,实现开放共享。提升8种~10种重大疾病和3种~5种疑难病中医药疗效水平,开发一批中医治未病技术并推广应用。提高中药资源保障水平和新药研发能力。形成不少于50项药典标准和100项行业标准,完成5个~10个中成药品种在欧美等发达国家作为药品注册;建立一批中医药研究中心与联合实验室,加强与“一带一路”沿线国家的合作。制定一批民族医特色诊疗技法技术标准,建立10种~15种民族医临床诊疗方案与指南;建立民族药资源数据库、民族药安全性、有效性评价等平台。

《规划》明确了发展前沿关键技术与创新方法、深化中医药理论传承与创新、提升中医药防治重大疾病水平、发展中医药健康服务技术、促进中药资源保障与价值提升、加强中药研发技术和产品开发、推进中医药标准化与国际化、加强民族医药传承与创新、构建中医药创新网络与支撑体系共9项重点任务。《规划》强调,要加强系统生物学、大数据、人工智能等多学科前沿技术与中医药的深度交叉融合;开展中医治未病、康复、仪器、中医药大数据开发及中医药“互联网+”服务技术研究,构建治未病技术体系。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1285367, encodeId=6dc6128536ea0, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Jun 18 03:19:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408956, encodeId=2849140895629, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 18 03:19:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617629, encodeId=1f74161e6293c, content=<a href='/topic/show?id=9e9ce4939a5' target=_blank style='color:#2F92EE;'>#科技创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74939, encryptionId=9e9ce4939a5, topicName=科技创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2cf19789758, createdName=12498bf3m31暂无昵称, createdTime=Sun Jun 18 03:19:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1285367, encodeId=6dc6128536ea0, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Jun 18 03:19:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408956, encodeId=2849140895629, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 18 03:19:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617629, encodeId=1f74161e6293c, content=<a href='/topic/show?id=9e9ce4939a5' target=_blank style='color:#2F92EE;'>#科技创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74939, encryptionId=9e9ce4939a5, topicName=科技创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2cf19789758, createdName=12498bf3m31暂无昵称, createdTime=Sun Jun 18 03:19:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2017-06-18 cathymary
  3. [GetPortalCommentsPageByObjectIdResponse(id=1285367, encodeId=6dc6128536ea0, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Jun 18 03:19:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408956, encodeId=2849140895629, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Jun 18 03:19:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617629, encodeId=1f74161e6293c, content=<a href='/topic/show?id=9e9ce4939a5' target=_blank style='color:#2F92EE;'>#科技创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74939, encryptionId=9e9ce4939a5, topicName=科技创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2cf19789758, createdName=12498bf3m31暂无昵称, createdTime=Sun Jun 18 03:19:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]